Skip to main content
Premium Trial:

Request an Annual Quote

Wasn't High Tech Supposed to Usher in the New World Order?

Portfolio magazine has an article about Decode Genetics, which it refers to as a "high-tech victim of the new world economic order." The article notes Nasdaq's delisting warning to the company, adding that "this comes against a backdrop of biotech markets that are not only plummeting, but may be facing particularly hard times as investors pull back from an industry that even in bullish times requires massive amounts of capital and years of R&D before revenues come in." CEO Kari Stefansson has said that his team is "in the process of creating a smaller, leaner Decode."


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.